Meningitis due to Listeria monocytogenes as a complication of infliximab therapy;Meningitis door Listeria monocytogenes als complicatie van behandeling met infliximab

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 30, 2003, Pages 1470-1472

  Joosten, A A J ^a   Van Olffen, G H ^a   Hageman, G ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; COTRIMOXAZOLE; INFLIXIMAB; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CROHN DISEASE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LISTERIA MONOCYTOGENES; MENINGITIS; OPPORTUNISTIC INFECTION;

ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; LISTERIA MONOCYTOGENES; MENINGITIS, LISTERIA; OPPORTUNISTIC INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042825971     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Tijhuis GJ, Putte LB van de, Breedveld FC. Behandeling van reumatoïde artritis door blokkade van tumornecrosisfactor met infliximab of etanercept. Ned Tijdschr Geneeskd 2001;145:1880-5.
2. Feldmann M, Elliott MJ, Woody JN, Maini RN. Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis. Adv Immunol 1997; 64:283-350.
3. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-25.
4. Choy EHS, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-16.
5. 2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
6. Kornbluth A. Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference. Inflamm Bowel Dis 1998;4:328-9.
7. Vonkeman HE, Valk PDLM van der, Mulder L, Laar MAFJ van de. Fatale miliaire tuberculose tijdens behandeling met infliximab. Ned Tijdschr Geneeskd 2002;146:1196-9.
8. Lee JH, Slifman NR, Gershon SK, Edwards ET, Schwieterman WD, Siegel JN, et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 2002;46:2565-70.
9. Nakane A, Minagawa T, Kato K. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun 1988;56:2563-9.
10. Hoogkamp-Korstanje JAA. Infecties door Listeria monocytogenes. Ned Tijdschr Geneeskd 1996;140:644-6.
11. Slifman NR, Gershon SK, Lee JH, Edwards ET, Braun MM. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum 2003;48:319-24.